307750 — Kukjeon Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Kukjeon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3,317	4,038	8,877	4,692	538
Depreciation
Amortisation
Non-Cash Items	9,689	1,839	-7,704	1,496	332
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	12,299	-3,938	-8,633	-9,602	4,126
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19,647	3,042	-6,019	-345	10,036
Capital Expenditures	-2,516	-10,418	-23,767	-38,020	-11,489
Purchase of Fixed Assets
Other Investing Cash Flow Items	-2,617	-22,161	-52,866	13,705	54,285
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-5,133	-32,579	-76,633	-24,314	42,796
Financing Cash Flow Items	20	0	-5.6	400	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,597	38,856	85,100	14,106	-17,002
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,916	9,320	2,447	-10,554	35,831